Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice

GPER1-mediated immunomodulation and neuroprotection in the myenteric plexus of a mouse model of Parkinson's disease

(2015) Mélissa Côté et al.   NEUROBIOLOGY OF DISEASE

The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease

(2015) Nadhir Litim et al.   NEUROPHARMACOLOGY

Antidepressive treatments for Parkinson's disease: A systematic review and meta-analysis

(2015) Emily Bomasang-Layno et al.   PARKINSONISM & RELATED DISORDERS

Serum choline plasmalogens, particularly those with oleic acid insn-2, are associated with proatherogenic state

(2014) Megumi Nishimukai et al.   JOURNAL OF LIPID RESEARCH

Raloxifene activates G protein-coupled estrogen receptor 1/Akt signaling to protect dopamine neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice

(2014) Mélanie Bourque et al.   NEUROBIOLOGY OF AGING

Promises of novel multi-target neuroprotective and neurorestorative drugs for Parkinson's disease

(2013) Moussa B.H. Youdim et al.   PARKINSONISM & RELATED DISORDERS

Plasmalogens Rescue Neuronal Cell Death through an Activation of AKT and ERK Survival Signaling

(2013) Md. Shamim Hossain et al.   PLoS One

A Guide to Neurotoxic Animal Models of Parkinson's Disease

(2013) K. Tieu   Cold Spring Harbor Perspectives in Medicine

Functions of plasmalogen lipids in health and disease

(2012) Nancy E. Braverman et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Animal models of Parkinson’s disease

(2012) Fabio Blandini et al.   FEBS Journal

Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson’s disease

(2012) Mélanie Bourque et al.   FRONTIERS IN NEUROENDOCRINOLOGY

Importance of cholesterol in dopamine transporter function

(2012) Kymry T. Jones et al.   JOURNAL OF NEUROCHEMISTRY

Implication of GPER1 in neuroprotection in a mouse model of Parkinson's disease

(2012) Mélanie Bourque et al.   NEUROBIOLOGY OF AGING

Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease

(2011) Paul L Wood et al.   Lipids in Health and Disease

In vitro and in vivo plasmalogen replacement evaluations in rhizomelic chrondrodysplasia punctata and Pelizaeus-Merzbacher disease using PPI-1011, an ether lipid plasmalogen precursor

(2011) Paul L Wood et al.   Lipids in Health and Disease

Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens

(2011) Paul L Wood et al.   Lipids in Health and Disease

Neurotoxin-based models of Parkinson's disease

(2011) J. Bové et al.   NEUROSCIENCE

Membrane plasmalogen composition and cellular cholesterol regulation: a structure activity study

(2010) Rishikesh Mankidy et al.   Lipids in Health and Disease

Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease

(2009) Charalampos Dragonas et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

A Biochemical and Functional Protein Complex Involving Dopamine Synthesis and Transport into Synaptic Vesicles

(2009) Etienne A. Cartier et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The scientific and clinical basis for the treatment of Parkinson disease (2009)

(2009) C. W. Olanow et al.   NEUROLOGY

MPTP-induced Parkinsonism is associated with damage to Leydig cells and testosterone loss

(2008) Riccardo Ruffoli et al.   BRAIN RESEARCH

Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson’s disease

(2007) M. Bousquet et al.   FASEB JOURNAL